Cholinesterase inhibitors for Parkinson’s disease-related visual hallucinations unresponsive to atypical antipsychotics
Journal Title: Archives of Medical Science - Year 2007, Vol 3, Issue 1
Abstract
Introduction: Considering lack of accepted guideline in cases of Parkinson’s disease-related visual hallucinations with poor response or intolerance to antipsychotics, and their possible cholinergic pathogenesis, the trial with cholinesterase inhibitors seems to be legitimated. Material and methods: Five patients with PD (with or without dementia) complicated by VH and unresponsive to atypical antipsychotics were offered a 12-week, open-label trial of a cholinesterase inhibitor. Results: All 5 subjects completed the trial with no major adverse effects and, noteworthy, no discontinuations due to adverse events. VH resolved in 4 subjects and were markedly diminished in one person. Neither changes in UPDRS scores nor exaggeration of subjective complaints about extrapyramidal symptoms were noted during treatment. Conclusions: Cholinesterase inhibitors, rivastigmine or donepezil, might represent a useful alternative to antipsychotics for patients with PD accompanied by VH even in the absence of dementia.
Authors and Affiliations
Tomasz Sobow
Keywords
Related Articles
- EP ID EP154668
- DOI -
- Views 175
- Downloads 0
Functional and biopsychosocial restrictions among patients with a venous ulcer
Introduction: The aim of the study was to assess physical and psychosocial problems of patients with a venous ulcer. Functioning, downfall risk, nutritional status and prevalence of depression were assessed. Relationship...
The role of endothelin in stroke: Experimental data and underlying pathophysiology
The role of endothelin in functional and structural changes after stroke is only partly understood: synthesis and release of the potent vasoconstrictor peptide endothelin-1 increases following ischemia and mediates the d...
Coronaviruses OC43 and 229E lower respiratory tract co-infections: a clinical report of two cases
Why does intensive insulin therapy implemented at the onset of type 1 diabetes not decrease prevalence of diabetic microangiopathy?
Short-term lifestyle intervention significantly increases fasting adiponectin and induces a decline in serum adiponectin during oral glucose tolerance test, without changes in insulin resistance
Introduction: Metabolic syndrome is associated with insulin resistance (IR) and low concentrations of adiponectin, an adipocytokine that improves insulin sensitivity and has anti-inflammatory and anti-atherogenic propert...